Literature DB >> 27942635

Theranostic TEMPO-functionalized Ru(ii) complexes as photosensitizers and oxidative stress indicators.

Jing Yang1, Qian Cao1, Wei-Liang Hu1, Rui-Rong Ye1, Liang He1, Liang-Nian Ji1, Peter Z Qin2, Zong-Wan Mao1.   

Abstract

New TEMPO-functionalized Ru(ii) polypyridyl complexes were synthesized as efficient theranostic photosensitizers for cancer treatment. Interestingly, due to the presence of a redox sensitive TEMPO moiety, an enhancement in the intracellular fluorescence of TEMPO-functionalized Ru(ii) complexes was observed during photodynamic treatment in both confocal microscopy and flow cytometry. This can be explained by the conversion of the TEMPO radical moiety to diamagnetic non-radical species in cells upon PDT-induced oxidative stress. To the best of our knowledge this is the first ruthenium complex capable of simultaneously inducing and monitoring the oxidative stress. The tethered TEMPO moiety decreased the inherent dark-cytotoxicity and increased the photo-toxicity simultaneously, both of which contributed to the greatly improved photodynamic therapy (PDT) efficacy, ultimately resulting in cancer cell apoptosis. The phototoxicity index value for TEMPO-functionalized Ru(ii) complexes was selective towards cancer cell lines (280.5 for HeLa cells vs. 30.2 for LO2 cells) and ca. 40-fold higher than that for TEMPO-free Ru(ii) analogues (6.7 for HeLa cells). The main contributor for such a greatly enhanced PDT efficacy was the effect of the TEMPO moiety on the cellular uptake and intracellular ROS levels. We therefore demonstrate that the combination of TEMPO with the photosensitizers may be an emerging strategy to develop novel photosensitizer-based theranostic platforms, which can induce and monitor the PDT response simultaneously.

Entities:  

Year:  2017        PMID: 27942635     DOI: 10.1039/c6dt04028d

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  3 in total

1.  4-Hydroxyl-oxoisoaporphine, one small molecule as theranostic agent for simultaneous fluorescence imaging and photodynamic therapy as type II photosensitizer.

Authors:  Qi Xu; Yunfan Ji; Meijun Chen; Xusheng Shao
Journal:  Photochem Photobiol Sci       Date:  2021-03-20       Impact factor: 3.982

2.  Mitochondria-targeted spin-labelled luminescent iridium anticancer complexes.

Authors:  V Venkatesh; Raul Berrocal-Martin; Christopher J Wedge; Isolda Romero-Canelón; Carlos Sanchez-Cano; Ji-Inn Song; James P C Coverdale; Pingyu Zhang; Guy J Clarkson; Abraha Habtemariam; Steven W Magennis; Robert J Deeth; Peter J Sadler
Journal:  Chem Sci       Date:  2017-10-20       Impact factor: 9.825

Review 3.  Recent developments in the nanostructured materials functionalized with ruthenium complexes for targeted drug delivery to tumors.

Authors:  Prakash Thangavel; Buddolla Viswanath; Sanghyo Kim
Journal:  Int J Nanomedicine       Date:  2017-04-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.